GM-CSF Treated F4/80(+) BMCs Improve Murine Hind Limb Ischemia Similar to M-CSF Differentiated Macrophages

Novel cell therapy is required to treat critical limb ischemia (CLI) as many current approaches require repeated aspiration of bone marrow cells (BMCs). The use of cultured BMCs can reduce the total number of injections required and were shown to induce therapeutic angiogenesis in a murine model of...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwahara, Go, Nishinakamura, Hitomi, Kojima, Daibo, Tashiro, Tadashi, Kodama, Shohta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159294/
https://www.ncbi.nlm.nih.gov/pubmed/25202910
http://dx.doi.org/10.1371/journal.pone.0106987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159294/
https://www.ncbi.nlm.nih.gov/pubmed/25202910
http://dx.doi.org/10.1371/journal.pone.0106987

Ejemplares similares